These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38040194)

  • 1. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
    Song X; Wang X; Chen X; Yu Z; Zhou Y
    J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression.
    Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
    Biomed Pharmacother; 2019 Jul; 115():108869. PubMed ID: 31028999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallium maltolate shows synergism with cisplatin and activates nucleolar stress and ferroptosis in human breast carcinoma cells.
    Chen CH; Huang YM; Grillet L; Hsieh YC; Yang YW; Lo KY
    Cell Oncol (Dordr); 2023 Aug; 46(4):1127-1142. PubMed ID: 37067747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis.
    Tao R; Liu Z; Zhang Z; Zhang Z
    Anticancer Drugs; 2024 Jul; 35(6):483-491. PubMed ID: 38502867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis.
    Wang L; Yang X; Zhou F; Sun X; Li S
    Bioengineered; 2022 Mar; 13(3):7197-7208. PubMed ID: 35263216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
    Li J; Gao R; Zhang J
    Clin Breast Cancer; 2023 Feb; 23(2):162-175. PubMed ID: 36528490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic mechanism of RBM15 in affecting cisplatin resistance in laryngeal carcinoma cells by regulating ferroptosis.
    Liang Y; Zhong H; Zhao Y; Tang X; Pan C; Sun J; Sun J
    Biol Direct; 2024 Jul; 19(1):57. PubMed ID: 39039611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
    Fu D; Wang C; Yu L; Yu R
    Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WTAP Mediates NUPR1 Regulation of LCN2 Through m
    Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
    Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
    Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
    Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol decreases cisplatin resistance of non-small cell lung cancer by inducing GPX4-mediated ferroptosis through the miR-744-5p/miR-615-3p axis.
    Han B; Liu Y; Zhang Q; Liang L
    J Proteomics; 2023 Mar; 274():104777. PubMed ID: 36427803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF12 induces ferroptosis by suppressing OTUB1-mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma.
    Liu Y; Bai Q; Pang N; Xue J
    Cell Biol Int; 2024 Nov; 48(11):1649-1663. PubMed ID: 38946134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma.
    Yong X; Zhang Y; Tang H; Hu H; Song R; Wu Q
    Anticancer Drugs; 2024 Sep; 35(8):698-708. PubMed ID: 38748610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells.
    Zeng D; Liang YK; Xiao YS; Wei XL; Lin HY; Wu Y; Bai JW; Chen M; Zhang GJ
    Int J Cancer; 2020 Jul; 147(2):490-504. PubMed ID: 32020593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
    Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
    Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroisotanshinone I regulates ferroptosis via PI3K/AKT pathway to enhance cisplatin sensitivity in lung adenocarcinoma.
    Li FJ; Gao LC; Long HZ; Zhou ZW; Luo HY; Xu SG; Dai SM; Hu JD
    J Pharm Pharmacol; 2024 Jul; ():. PubMed ID: 39045884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.